| Unaudited Reconciliation of Net Income to Adjusted EBITDA | ||||||||||||
| Three Months Ended | ||||||||||||
| (in millions USD) | June 30, 2023 | March 31, 2023 | June 30, 2022 | |||||||||
| Net income for the period | $ | 237 | $ | 254 | $ | 264 | ||||||
| Depreciation and amortization | 340 | 343 | 411 | |||||||||
| Finance expense | 34 | 31 | 26 | |||||||||
| Finance income | (34 | ) | (32 | ) | NA | |||||||
| Income tax expense | 28 | 23 | 30 | |||||||||
| Share-based compensation | 44 | 31 | 53 | |||||||||
| Restructuring charges | 19 | 5 | — | |||||||||
| Adjusted EBITDA (1)(2) | $ | 668 | $ | 655 | $ | 784 | ||||||
| Adjusted EBITDA margin (2) | 36.2 | % | 35.6 | % | 39.3 | % | ||||||
| (1) Reflects change to adjusted EBITDA definition discussed in more detail elsewhere in this release. | ||||||||||||
| (2) Adjusted EBITDA and related margin are Non-IFRS measures. See “Unaudited Reconciliation of IFRS to Non-IFRS" for a detailed reconciliation of Non-IFRS measures to the most directly comparable IFRS measure. See "Financial Measures (Non-IFRS)" for a discussion of why we believe these Non-IFRS measures are useful. | ||||||||||||
Financial Measures (Non-IFRS)
